177 related articles for article (PubMed ID: 22950625)
1. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Yang B; Su K; Gao J; Rao Z
Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Neoplasma; 2013; 60(3):254-61. PubMed ID: 23373994
[TBL] [Abstract][Full Text] [Related]
4. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
[TBL] [Abstract][Full Text] [Related]
8. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
Elzagheid A; Emaetig F; Alkikhia L; Buhmeida A; Syrjänen K; El-Faitori O; Latto M; Collan Y; Pyrhönen S
Anticancer Res; 2013 Aug; 33(8):3137-43. PubMed ID: 23898071
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C
J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719
[TBL] [Abstract][Full Text] [Related]
10. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
[TBL] [Abstract][Full Text] [Related]
12. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
[TBL] [Abstract][Full Text] [Related]
15. MMP13 is a potential prognostic marker for colorectal cancer.
Huang MY; Chang HJ; Chung FY; Yang MJ; Yang YH; Wang JY; Lin SR
Oncol Rep; 2010 Nov; 24(5):1241-7. PubMed ID: 20878116
[TBL] [Abstract][Full Text] [Related]
16. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
Jang SH; Min KW; Paik SS; Jang KS
J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
[TBL] [Abstract][Full Text] [Related]
17. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
18. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
19. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
